Biopaint

Biopaint was a biotechnology company focused on developing innovative nanotechnology platforms for healthcare, specifically in the fields of diagnostics and medical device functionalization. The company's core expertise lay in the creation of bio-functional coatings and molecular probes designed to enhance the detection and treatment of cardiovascular and oncological conditions. One of its primary technological pillars was the Restricted Interaction Peptide Technology (RIPT), which enabled the real-time, non-invasive imaging of blood clots and cellular tracking. Although recognized as a promising player in the Italian 'Red Biotech' sector and a spin-off from academic research at UCSF, the company is currently inactive or in liquidation.